1 / 52

MOLECULAR DIAGNOSITICS

MOLECULAR DIAGNOSITICS. Prof. Fang Zheng, Tianjin Medical University. Introduction to Molecular Diagnostics. Outline. Concept of Molecular Diagnostics History of Molecular Diagnostics Impact on Human Diseases Basis for Molecular Assay Management of the course.

ifama
Download Presentation

MOLECULAR DIAGNOSITICS

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. MOLECULAR DIAGNOSITICS Prof. Fang Zheng, Tianjin Medical University

  2. Introduction to Molecular Diagnostics

  3. Outline • Concept of Molecular Diagnostics • History of Molecular Diagnostics • Impact on Human Diseases • Basis for Molecular Assay • Management of the course

  4. Concept of Molecular Diagnostics • History of Molecular Diagnostics • Impact on Human Diseases • Basis for Molecular Assay • Management of the course

  5. 1. Molecular Diagnosis Molecular diagnosis of human disorders is referred to as the detection of the various pathogenic mutations in DNA and /or RNA samples in order to facilitate detection, diagnosis, sub-classification, prognosis, and monitoring response to therapy.

  6. 1. Molecular Diagnostics The use of molecular biology techniques to expand scientific knowledge of the natural history of diseases, identify people who are at risk for acquiring specific diseases, and diagnose human diseases at the nucleic acid level.

  7. 1. Molecular Diagnostics Molecular diagnostics combines laboratory medicine with the knowledge and technology of molecular genetics and has been enormously revolutionized over the last decades, benefiting from the discoveries in the field of molecular biology.

  8. 1. Molecular Diagnostics: Emergence • The information revolution in molecular biology is permeating every aspect of medical practice • The rate of disease gene discovery is increasing exponentially, which facilitates the understanding diseases at molecular level • Molecular understanding of disease is translated into diagnostic testing, therapeutics, and eventually preventive therapies

  9. 1. Molecular Diagnostics: Significance To face the new century, the medical practitioner not only understand molecular biology, but must also embrace the use of this rapidly expanding body of information in his medical practice, whether practicing family medicine, oncology, obstetrics and gynecology, pathology, or any other medical specialty.

  10. 1. Molecular Diagnostics: Goal • To introduce essential concepts in molecular diagnostics that impact on the identification of novel markers of human diseases • To develop and apply useful molecular assays to monitor disease, determine appropriate treatment strategies, and predict disease outcomes.

  11. Concept of Molecular Diagnostics • History of Molecular Diagnostics • Impact on Human Diseases • Basis for Molecular Assay • Management of the course

  12. 2. History of Molecular Diagnostics The Molecular Biology Timeline 1865 Gregor Mendel, Law of Heredity 1866 Johann Miescher, Purification of DNA 1949 Sickle Cell Anemia Mutation Watson and Crick, Structure of DNA 1953 Recombinant DNA Technology 1970 DNA sequencing 1977 In Vitro Amplification of DNA (PCR) 1985 2001 The Human Genome Project

  13. 2. History of Molecular Diagnostics Sickle cell anemia • Sickle cell anemia is a genetic disease which is caused by a single nucleotide change in the 6th aa of the -chain of hemoglobin. • Pauling introduced the term molecular disease in the medical vocabulary, based on their discovery that a single amino acid change leads to a sickle cell anemia. • In principle, their findings have set the foundations of molecular diagnostics.

  14. Sickle Cell Anemia Figure A. Normal red blood cells flowing freely in a blood vessel. The inset image shows a cross-section of a normal red blood cell with normal hemoglobin. Figure B. Abnormal, sickled red blood cells clumping and blocking blood flow in a blood vessel. The inset image shows a cross-section of a sickle cell with abnormal hemoglobin.

  15. Discovery of DNA Structure J.D. Watson and F.H.C. Crick (1953) A structure for deoxyribose nucleic acid. Nature 171:737 “We wish to suggest a structure for the salt of deoxyribose nucleic acid (D.N.A.). This structure has novel features which are of considerable biological interest.” One of the most important biological discovery in the 20th century

  16. Discovery of DNA Structure J.D. Watson and F.H.C. Crick (1953)

  17. Discovery of DNA Structure Rosalind E. Franklin 1920–1958 The structure of DNA was determined using X-ray diffraction techniques. Much of the original X-ray diffraction data was generated by Rosalind E. Franklin.

  18. Discovery of DNA Structure Laboratory of Molecular Biology,(LMB) (Cavendish  Laboratory ) 1955- 12 scientists received Noble Prize • J. Watson & F. Crick: DNA structure • Max Perutz & John Kendrew: Protein sequence • Frederick Sanger: Insulin sequence • Frederick Sanger: DNA sequencing • Cesar Milstein & Georges Kohler: Monoclonal Ab • ……

  19. 2. History of Molecular Diagnostics • The first seeds of molecular diagnostics were provided in the early days of recombinant DNA technology. • cDNA cloning and sequencing were invaluable tools for providing the basic knowledge on the primary sequence of various genes. • DNA sequencingprovided a number of DNA probes, allowing the analysis via southern blotting of genomic regions, leading to the concept and application of restriction fragment length polymorphism (RELP) track a mutant allele from heterozygous parents to a high-risk pregnancy.

  20. 2. History of Molecular Diagnostics The PCR Revolution Kary Mullis 1985 41y Invention of PCR 1993 49y Received the Noble Prize

  21. 2. History of Molecular Diagnostics The PCR Revolution PCR has greatly facilitated and revolutionized molecular diagnostics. Its most powerful feature - large amount of copies of the target sequence generated by its exponential amplification, which allows the identification of a known mutation within a single day.

  22. 2. History of Molecular Diagnostics The PCR Revolution PCR markedly decreased need for radioactivity, allowed molecular diagnostics to enter the clinical laboratory. PCR either is used for the generation of DNA fragments to be analyzed, or is part of the detection methods

  23. 2. History of Molecular Diagnostics Human Genome Project • U.S. Government project coordinated by the Dept. of Energy and NIH • Goals of the Human Genome Project (1990–2006) – To identify all of the genes in human DNA; – To determine the sequences of the 3 billion bases that make up human DNA; – To create databases; – To develop tools for data analysis; and – To address the ethical, legal, and social issues that arise from genome research

  24. 2. History of Molecular Diagnostics Human Genome Project • U.S. Government project coordinated by the Dept. of Energy and NIH • Goals of the Human Genome Project (1990–2006) – To identify all of the genes in human DNA; – To determine the sequences of the 3 billion bases that make up human DNA; – To create databases; – To develop tools for data analysis; and – To address the ethical, legal, and social issues that arise from genome research

  25. Concept of Molecular Diagnostics • History of Molecular Diagnostics • Impact on Human Diseases • Basis for Molecular Assay • Management of the course

  26. 3. Impact on Human Diseases: Novelty • Discovery of potential novel molecular markers of human diseases • Identification of novel molecular markers of human diseases • Utility of molecular markers to develop useful molecular assays for detection, diagnosis, and prediction of disease outcomes

  27. 3. Impact on Human Diseases: Advantage • Monitor diseases more accurately • Allows for early treatment and better patient care • Determine most appropriate treatment • Reduces or eliminates unnecessary treatment • Reduces or eliminates inadequate treatment • Yields greater cost effectiveness • Reduce patient morbidity and mortality

  28. 3. Impact on Human Diseases: Practical application • Diagnostic-Identity of a disease • Prognostic-Outcome of a disease • Predictive-Possibility of a disease • Therapeutic-Response of a disease to treatment

  29. INFECTIOUS DISEASE HEMATOLOGY Molecular Pathology SOLID TUMORS IDENTITY TESTING GENETIC DISEASE 3. Impact on Human Diseases

  30. 3. Impact on Human Diseases • Molecular Genetics • • Single gene disorders • 病种多,特定家系中发病率高,对群体影响小, • 遗传性基因携带者的筛查 • • Polygenic disorders • 病种少,特定家系中发病率高,对群体影响大 • 遗传易感性的检测 • • Chromosomal disorders

  31. 3. Impact on Human Diseases • Molecular Oncology • • Diagnostic testing • • Disease prognosis • • Determination of predisposition

  32. 3. Impact on Human Diseases • Hematopathology • • Diagnostic testing • • Determination of clonality • Identity Testing • • Parentage • • Clinical testing

  33. 3. Impact on Human Diseases • Infectious Disease • • Qualitative and quantitative detection of infectious agents • • Microbial identity testing • • Genotyping/drug resistance testing

  34. Concept of Molecular Diagnostics • History of Molecular Diagnostics • Impact on Human Diseases • Basis for Molecular Assay • Management of the course

  35. 4. Basis for Technology: Fundamental (1) Advance in the understanding of the structure and chemistry of nucleic acids have facilitated the development of technologies that can be employed effectively in molecular diagnostics.

  36. 4. Basis for Technology: Platform Molecular Technologies in the Clinical Laboratory • Amplification Techniques • PCR polymerase chain reaction多聚酶链反应 • LCR ligase chain reaction 连接酶链反应 • NASBA nucleic-acid sequence-based amplification • 核酸序列依赖的扩增 • DNA Sequencing

  37. 4. Basis for Technology: Platform Molecular Technologies in the Clinical Laboratory • Hybridization Techniques • Southern hybridization Blot • Northern hybridization Blot • Electrophoretic Methods • SSCP (single-strand conformation polymorphism) • 单链构象多态性 • DGGE (denaturing gradient gel electrophoresis) • 变性梯度凝胶电泳法

  38. 4. Basis for Technology: Platform Molecular Technologies in the Clinical Laboratory • Recombinant DNA Technology • Biochip Technology • DNA micro-array • Protein micro-array

  39. 4. Basis for Technology: Target specialty Nucleic acids are targeted by molecular assays • Genetically-based diseases can be diagnosed • Specificity can be controlled • Single base changes can be detected • Expression of gene product is not required • Targets can be amplified >105

  40. Cause (etiology) Mechanism (pathogenesis) Structural alterations (morphologic/molecular) Functional consequences (clinical significance) 4. Basis for Molecular Assays: Diseases

  41. 4. Basis for Molecular Assay: Pathogenesis (1) Understanding molecular pathogenesis of human disease enables effective utilization of molecular assays Diagnostic • Distinguishing variants of human disease based on presence of specific molecular markers (chromosome translocations in Burkitt’s lymphoma: c-myc)

  42. 4. Basis for Molecular Assay: Pathogenesis (1) Understanding molecular pathogenesis of human disease enables effective utilization of molecular assays Prognostic • Prediction of likely patient outcomes based on presence of specific molecular markers (gene mutations predicting clinical course in cancer)

  43. 4. Basis for Molecular Assay: Pathogenesis (2) Understanding molecular pathogenesis of human disease enables effective utilization of molecular assays Therapeutic • Prediction of response to specific therapies based on presence of specific molecular markers (gene mutations predicting poor drug sensitivity inlung cancer: p53, k-ras)

  44. 4. Basis for Molecular Assay:Molecular biology (1) • Genetic Lesions in Human Disease • • Identification of genetic markers • • Identification of disease-related genes • • Molecular targets for assay development

  45. 4. Basis for Molecular Assay:Molecular biology (1) • Characterization of Gene Sequences • • Facilitates characterization of disease-causing mutations • • Molecular targets for assay development

  46. 4. Basis for Molecular Assay:Molecular biology (2) Completion of the sequence of the human genome will enable identification of all human genes and establishment of disease-gene relationships, facilitating development of numerous new molecular assays.

  47. 4. Basis for Molecular Assay:Molecular biology (4) Beneficial outcomes from human genome project • Improvements in medicine • Microbial genome research • DNA forensics/identity • Improved agriculture and livestock • Better understanding of evolution and human migration • More accurate risk assessment

  48. 4. Basis for Molecular Assay:Molecular biology (5) Human genome project: Ethical, Legal, and Social Implications • Use of genetic information • Privacy/confidentiality • Psychological impact • Genetic testing • Reproductive options/issues • Education, standards, and quality control • Commercialization • Conceptual and philosophical implications

  49. 5. Conclusion • What’s So Great About • Molecular Diagnostics? • As many as 5,000 diseases have direct genetic causes • High sensitivity and increased specificity for most • tests adds diagnostic utility • Potential for simple standardized procedures an • automation • rapid throughput • Increased number of techniques for infectious diseases • and tumor diagnostics • A viable reflex for equivocal morphology • Prices are falling

More Related